Masimo | MASI - Cash And Equivalent


Masimo reported $312.3M in Cash and Equivalent for its fiscal quarter ending in September of 2025.





Cash And Equivalent Change Date
Abbott USD 7.51B 560M Sep/2025
Align Technology USD 1B 103.43M Sep/2025
AtriCure USD 147.86M 30.07M Sep/2025
Avanos Medical USD 70.5M 19.8M Sep/2025
Baxter International USD 1.73B 40M Sep/2025
Becton, Dickinson and Co. USD 641M 94M Sep/2025
Boston Scientific USD 1.28B 741M Sep/2025
Dexcom USD 1.84B 676.7M Sep/2025
Edwards Lifesciences USD 2.69B 587.2M Sep/2025
General Electric Aerospace USD 12.39B 109M Dec/2025
Globus Medical USD 229.45M 231.82M Jun/2025
Haemonetics USD 363.37M 66.94M Dec/2025
Insulet USD 757.4M 364.2M Sep/2025
Integra LifeSciences USD 232.19M 14.27M Sep/2025
Intuitive Surgical USD 9.03B 601.6M Dec/2025
Masimo USD 312.3M 162.7M Sep/2025
Medtronic USD 1.28B 9M Sep/2025
Owens Minor USD 32.84M 5.42M Sep/2025
ResMed USD 1.42B 33.22M Dec/2025
Steris USD 423.7M 104.5M Dec/2025
Stryker USD 3.26B 881M Sep/2025
Tandem Diabetes Care USD 91.95M 27.83M Sep/2025
Teleflex USD 354M 100.3M Sep/2025
Thermo Fisher Scientific USD 9.85B 7.87B Dec/2025
Zimmer Biomet Holdings USD 1.29B 735.8M Sep/2025